Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
Industry News
News|Aug 9 2021
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
Industry News
Blog|Aug 9 2021
Meet The Community: Madison Hardwick
Community
Blog|Aug 2 2021
Meet The Community: Cristian Florian Bondarenco
Community
Blog|Jul 26 2021
Meet the Community – Shelby Wright
Community
Blog|Jul 19 2021
Meet The Community: Caroline Spencer
Community
Blog|Jul 12 2021
Meet the Community – Christiane Wick-Jüttner
Community
Blog|Jul 6 2021
Meet the Community – Ribar Mohamad
Community
News|Jun 30 2021
Lexeo Therapeutics Receives Rare Pediatric Disease & Orphan Drug Designations for LX2006
Industry News
News|Jun 30 2021
LEXEO Therapeutics Announces License Agreement and Consolidation of Pre-clinical Data Package to Support Cardiac Friedreich’s Ataxia Gene Therapy Program (LX2006)